NGNE

NGNE

USD

Neurogene Inc. Common Stock

$26.750+0.625 (2.392%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$26.125

Haut

$26.970

Bas

$23.930

Volume

0.16M

Fondamentaux de l'Entreprise

Capitalisation Boursière

381.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.20M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $6.875Actuel $26.750Haut $74.49

Actualités Connexes

Analyst Upgrades

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.

Voir plus
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Neurogene, Raises Price Target to $65

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Neurogene with a Buy and raises the price target from $45 to $65.

Voir plus
HC Wainwright & Co. Maintains Buy on Neurogene, Raises Price Target to $65